全文获取类型
收费全文 | 173篇 |
免费 | 6篇 |
专业分类
财政金融 | 13篇 |
工业经济 | 7篇 |
计划管理 | 47篇 |
经济学 | 28篇 |
综合类 | 60篇 |
运输经济 | 1篇 |
贸易经济 | 13篇 |
经济概况 | 10篇 |
出版年
2024年 | 1篇 |
2023年 | 3篇 |
2020年 | 4篇 |
2019年 | 3篇 |
2018年 | 4篇 |
2017年 | 6篇 |
2016年 | 4篇 |
2015年 | 5篇 |
2014年 | 13篇 |
2013年 | 19篇 |
2012年 | 22篇 |
2011年 | 26篇 |
2010年 | 18篇 |
2009年 | 7篇 |
2008年 | 10篇 |
2007年 | 9篇 |
2006年 | 9篇 |
2005年 | 4篇 |
2004年 | 4篇 |
2003年 | 2篇 |
2002年 | 4篇 |
2001年 | 1篇 |
2000年 | 1篇 |
排序方式: 共有179条查询结果,搜索用时 93 毫秒
71.
刘丽欣 《沈阳工程学院学报(社会科学版)》2002,(1):29-30
培养大学生口语交际能力、提高他们运用英语的能力已是摆在广大教师面前迫在眉睫的任务 ,本文就营造英语语境以及在听力课和精读课融入口语教学进行了论述 相似文献
72.
何玉沛 《长春金融高等专科学校学报》2008,(1):60-62
英语口语的重要性越来越得到认可,英语口语表达能力的培养也越来越受到重视。提高英语口语教学水平一方面要从学生学习角度、教师教学角度对英语口语教学进行研究,同时也有必要对教师如何提高自己的素质进行探讨。 相似文献
73.
张月琴 《安徽工业大学学报(社会科学版)》2002,19(2):93-94,129
口语测试理论的发展既有理论基础,又有社会实践基础.它的发展经历了三代不同的测试体系,即科学前测试体系、结构主义测试体系和交际测试体系.直接型口试、间接型口试、半直接型口式是口语测试理论的具体应用. 相似文献
74.
本文是对国外期刊《Biomechanical Analysis of the men's discus throw in the Athens 2006 IAAF world cup in the athletics》翻译,参考了部分有价值的数据,搜集了国内当前优秀男子铁饼运动李少杰的一些运动学参数,通过对比分析,找出我国目前优秀男子铁饼运动员同世界优秀运动员的技术差异,为指导今后的训练和教学实践提供有关数据和科学依据。 相似文献
75.
76.
大学英语教学改革对大学英语口语教学提出新的、更高的要求。目前大学英语教学理念中存在"重输出、轻输入"的误区。认知语言学认为,口语交际是一种认知体验活动,本文拟对认知心理空间在大学英语口语教学中作用之认知理据进行探讨。 相似文献
77.
Janna Manjelievskaia Antoine C. El Khoury Anna Vlahiotis Ashley Cole Paul Juneau 《Journal of medical economics》2013,16(12):1221-1229
AbstractBackground: Much of the burden associated with schizophrenia is attributed to its early onset and chronic nature. Treatment with once monthly paliperidone palmitate (PP1M) is associated with lower healthcare utilization and better adherence as compared to oral atypical antipsychotics (OAAs). This study aimed to evaluate real-world effectiveness of PP1M and OAA therapies among US-based adult Medicaid patients with schizophrenia, overall and among young adults aged 18–35 years.Methods: Adult patients with a diagnosis of schizophrenia and at least two claims for PP1M or OAA between January 1, 2010 and December 31, 2014 were selected from the IBM Watson Health MarketScan Medicaid Database. Treatment patterns and healthcare resource utilization and costs were compared between PP1M and OAA treatment groups following inverse probability of treatment (IPT) weighting to adjust for potential differences. Utilization and cost outcomes were estimated using OLS and weighted Poisson regression models.Results: After IPT weighting, the young adult PP1M and OAA cohorts were comprised of 3,095 and 3,155 patients, respectively. PP1M patients had a higher duration of continuous treatment exposure (168.2 vs 132.5 days, p?=?.004) and better adherence on the index medication (proportion of days covered ≥80%: 19.0% vs 17.1%, p?<?.049). Young adults treated with PP1M were 37% less likely to have an all-cause inpatient admission (odds ratio [OR]?=?0.63, 95% confidence interval [CI]?=?0.53–0.74) and 33% less likely to have an ER visit (OR?=?0.67, 95% CI?=?0.55–0.81) compared to OAA young adult patients, but 27% more likely to have an all-cause outpatient office visit (OR?=?1.27, 95% CI?=?1.02–1.56). PP1M patients incurred significantly lower medical costs as compared to OAA patients.Conclusions: Medicaid patients with schizophrenia treated with PP1M have higher medication adherence and have fewer hospitalizations as compared to patients treated with OAAs. PP1M may lead to reduced healthcare utilization and improved clinical outcomes. 相似文献
78.
《Journal of medical economics》2013,16(6):1217-1225
AbstractObjective:To examine healthcare costs among patients hospitalized for transient ischemic attack or ischemic stroke (TIA/stroke) and prescribed aspirin plus extended-release dipyridamole (ASA-ERDP) or clopidogrel (CLOPID) within 30 days post-discharge using a retrospective claims database from a large US managed care organization.Methods:Adult patients with ≥1 hospitalizations for TIA/stroke between January 2007–July 2009 and ≥1 claims for an oral anti-platelet (OAP) were observed for 1 year before and after the first TIA/stroke hospitalization or until death, whichever came first. Cohorts were defined by the first claim for ASA-ERDP or CLOPID within 30 days post-discharge. A generalized linear model, adjusting for demographics, baseline comorbidities and costs, compared total follow-up costs (medical?+?pharmacy) between ASA-ERDP and CLOPID patients.Results:Of 6377 patients (2085 ASA-ERDP; 4292 CLOPID) who met the selection criteria, mean (SD) age was 69 (13) years and 50% were male. Unadjusted mean total follow-up costs were lower for ASA-ERDP than CLOPID ($26,201 vs $30,349; p?=?0.002), of which average unadjusted medical and pharmacy costs were $22,094 vs $26,062 (p?=?0.003) and $4107 vs $4288 (p?=?0.119), respectively. Multivariate modeling indicated that the following were associated with higher total costs (all p?<?0.05): higher baseline Quan-Charlson comorbidity score, history of atrial fibrillation and myocardial infarction, index stroke hospitalization, death post-discharge, and index CLOPID use. Adjusted mean total follow-up costs for CLOPID were 9% higher than ASA-ERDP (cost ratio: 1.09; p?=?0.038).Conclusion:In this study, compared to CLOPID patients, ASA-ERDP patients were observed to have lower total costs 1 year post-discharge TIA/stroke hospitalization, driven primarily by lower medical costs. Further research into the real-world impact of OAP therapies on clinical and economic outcomes of patients with stroke/TIA is warranted. The findings of this study should be considered within the limitations of an administrative claims analysis, as claims data are collected for the purpose of payment. 相似文献
79.
80.